Header Logo

Connection

WAYNE GOODMAN to Adolescent

Back to Details
This is a "connection" page, showing publications WAYNE GOODMAN has written about Adolescent.
WAYNE GOODMAN
Connection Strength
1.697
Adolescent
  1. Randomized trial comparing standard versus light intensity parent training for anxious youth. Behav Res Ther. 2024 02; 173:104451.
    View in: PubMed
    Score: 0.064
  2. Impact of the COVID-19 pandemic on exposure and response prevention outcomes in adults and youth with obsessive-compulsive disorder. Psychiatry Res. 2021 01; 295:113597.
    View in: PubMed
    Score: 0.051
  3. Little Doubt That CBT Works for Pediatric OCD. J Am Acad Child Adolesc Psychiatry. 2020 07; 59(7):785-787.
    View in: PubMed
    Score: 0.050
  4. Psychiatric Diagnoses and Medications for Hurricane Harvey Sheltered Evacuees. Community Ment Health J. 2019 10; 55(7):1099-1102.
    View in: PubMed
    Score: 0.046
  5. Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition. J Am Acad Child Adolesc Psychiatry. 2019 01; 58(1):92-98.
    View in: PubMed
    Score: 0.044
  6. Meeting the Mental Health Needs of Hurricane Harvey Evacuees. Am J Psychiatry. 2018 Jan 01; 175(1):13-14.
    View in: PubMed
    Score: 0.042
  7. Altered olfactory processing and increased insula activity in patients with obsessive-compulsive disorder: An fMRI study. Psychiatry Res Neuroimaging. 2017 Apr 30; 262:15-24.
    View in: PubMed
    Score: 0.040
  8. The anxiety severity interview for children and adolescents: an individualized repeated measure of anxiety severity. Clin Psychol Psychother. 2014 Nov-Dec; 21(6):525-35.
    View in: PubMed
    Score: 0.031
  9. Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD. Psychiatry Res. 2013 Feb 28; 205(3):253-61.
    View in: PubMed
    Score: 0.029
  10. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr. 2012 Feb; 160(2):314-9.
    View in: PubMed
    Score: 0.027
  11. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist. J Anxiety Disord. 2010 Aug; 24(6):650-6.
    View in: PubMed
    Score: 0.025
  12. Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates. Soc Psychiatry Psychiatr Epidemiol. 2009 Nov; 44(11):935-42.
    View in: PubMed
    Score: 0.023
  13. Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist. J Clin Psychol. 2008 Dec; 64(12):1338-51.
    View in: PubMed
    Score: 0.022
  14. Insight in pediatric obsessive-compulsive disorder: associations with clinical presentation. Psychiatry Res. 2008 Aug 15; 160(2):212-20.
    View in: PubMed
    Score: 0.022
  15. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2008 May; 47(5):583-592.
    View in: PubMed
    Score: 0.021
  16. SSRI adverse events: how to monitor and manage. Int Rev Psychiatry. 2008 Apr; 20(2):203-8.
    View in: PubMed
    Score: 0.021
  17. Cognitive-behavioral therapy for obsessive-compulsive disorder: a non-randomized comparison of intensive and weekly approaches. J Anxiety Disord. 2008 Oct; 22(7):1146-58.
    View in: PubMed
    Score: 0.021
  18. Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorder. Acta Psychiatr Scand. 2008 Jan; 117(1):67-75.
    View in: PubMed
    Score: 0.021
  19. Sleep-related problems in pediatric obsessive-compulsive disorder. J Anxiety Disord. 2008 Jun; 22(5):877-85.
    View in: PubMed
    Score: 0.021
  20. Florida Obsessive-Compulsive Inventory: development, reliability, and validity. J Clin Psychol. 2007 Sep; 63(9):851-9.
    View in: PubMed
    Score: 0.021
  21. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2007 Jul; 22(4):230-7.
    View in: PubMed
    Score: 0.020
  22. Associations between miscellaneous symptoms and symptom dimensions: an examination of pediatric obsessive-compulsive disorder. Behav Res Ther. 2007 Nov; 45(11):2593-603.
    View in: PubMed
    Score: 0.020
  23. Clinical features of children and adolescents with obsessive-compulsive disorder and hoarding symptoms. Compr Psychiatry. 2007 Jul-Aug; 48(4):313-8.
    View in: PubMed
    Score: 0.020
  24. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry. 2007 Apr; 46(4):469-478.
    View in: PubMed
    Score: 0.020
  25. Sequential cognitive-behavioral therapy for children with obsessive-compulsive disorder with an inadequate medication response: a case series of five patients. Depress Anxiety. 2007; 24(6):375-81.
    View in: PubMed
    Score: 0.020
  26. Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl). 2007 Mar; 191(1):87-96.
    View in: PubMed
    Score: 0.020
  27. Factor-analytic study of the Yale Global Tic Severity Scale. Psychiatry Res. 2007 Jan 15; 149(1-3):231-7.
    View in: PubMed
    Score: 0.020
  28. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: findings from a preliminary waitlist controlled open trial. J Am Acad Child Adolesc Psychiatry. 2006 Oct; 45(10):1171-8.
    View in: PubMed
    Score: 0.019
  29. Obsessive-compulsive disorder in Tourette syndrome. J Child Neurol. 2006 Aug; 21(8):704-14.
    View in: PubMed
    Score: 0.019
  30. The children's Yale-Brown obsessive-compulsive scale: psychometric properties of child- and parent-report formats. J Anxiety Disord. 2006; 20(8):1055-70.
    View in: PubMed
    Score: 0.018
  31. Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorder. Depress Anxiety. 2006; 23(7):429-33.
    View in: PubMed
    Score: 0.018
  32. Reliability and validity of the Yale Global Tic Severity Scale. Psychol Assess. 2005 Dec; 17(4):486-91.
    View in: PubMed
    Score: 0.018
  33. Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials. J Affect Disord. 2005 Aug; 87(2-3):161-7.
    View in: PubMed
    Score: 0.018
  34. Factor analytic study of the Children's Yale-Brown Obsessive-Compulsive Scale. J Clin Child Adolesc Psychol. 2005 Jun; 34(2):312-9.
    View in: PubMed
    Score: 0.018
  35. Escitalopram for the treatment of GAD: efficacy across different subgroups and outcomes. Ann Clin Psychiatry. 2005 Apr-Jun; 17(2):71-5.
    View in: PubMed
    Score: 0.017
  36. Yale-Brown Obsessive Compulsive Scale: the dimensional structure revisited. Depress Anxiety. 2005; 22(1):28-35.
    View in: PubMed
    Score: 0.017
  37. Problematic Substance Use in Depressed Youth: Associations with Suicidal Ideation and Suicide Attempt History. J Dual Diagn. 2025 Jan-Mar; 21(1):35-48.
    View in: PubMed
    Score: 0.017
  38. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale. Psychiatry Res. 2004 Nov 30; 129(1):91-8.
    View in: PubMed
    Score: 0.017
  39. Parent perceptions of various treatment approaches for PANS and PANDAS. J Affect Disord. 2025 Jan 15; 369:1215-1222.
    View in: PubMed
    Score: 0.017
  40. Obsessive-Compulsive Disorder in Children and Adolescents. Annu Rev Clin Psychol. 2024 Jul; 20(1):355-380.
    View in: PubMed
    Score: 0.016
  41. Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges. Paediatr Drugs. 2024 Jul; 26(4):397-409.
    View in: PubMed
    Score: 0.016
  42. The clinical presentation of major depressive disorder in youth with co-occurring obsessive-compulsive disorder. J Affect Disord. 2024 Mar 15; 349:349-357.
    View in: PubMed
    Score: 0.016
  43. Efficacy and acceptability of cognitive-behavioral therapy and serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder: a network meta-analysis. J Child Psychol Psychiatry. 2024 05; 65(5):594-609.
    View in: PubMed
    Score: 0.016
  44. Further psychometric properties of the Tourette's Disorder Scale-Parent Rated version (TODS-PR). Child Psychiatry Hum Dev. 2004; 35(2):107-20.
    View in: PubMed
    Score: 0.016
  45. Alterations in attentional processing in youth with misophonia: A phenotypical cross-comparison with anxiety patients. J Affect Disord. 2024 02 15; 347:429-436.
    View in: PubMed
    Score: 0.016
  46. Family Accommodation in Children and Adolescents With Misophonia. Behav Ther. 2024 May; 55(3):595-604.
    View in: PubMed
    Score: 0.016
  47. Parent-Led Cognitive Behavioral Teletherapy for Anxiety in Autistic Youth: A Randomized Trial Comparing Two Levels of Therapist Support. Behav Ther. 2024 May; 55(3):499-512.
    View in: PubMed
    Score: 0.016
  48. Measuring misophonia in youth: A psychometric evaluation of child and parent measures. J Affect Disord. 2023 10 01; 338:180-186.
    View in: PubMed
    Score: 0.015
  49. Anger Outbursts in Youth with ASD and Anxiety: Phenomenology and Relationship with Family Accommodation. Child Psychiatry Hum Dev. 2024 Oct; 55(5):1259-1268.
    View in: PubMed
    Score: 0.015
  50. Clinical characteristics, impairment, and psychiatric morbidity in 102 youth with misophonia. J Affect Disord. 2023 03 01; 324:395-402.
    View in: PubMed
    Score: 0.015
  51. The Relationship Between Adverse Childhood Experiences, Symptom Severity, Negative Thinking, Comorbidity, and Treatment Response in Youth with Obsessive-Compulsive Disorder. Child Psychiatry Hum Dev. 2024 Oct; 55(5):1201-1210.
    View in: PubMed
    Score: 0.015
  52. Stepped-Care Cognitive Behavioral Therapy in Children on the Autism Spectrum with Co-occurring Anxiety. J Autism Dev Disord. 2024 Jan; 54(1):93-108.
    View in: PubMed
    Score: 0.015
  53. Perceptions of various treatment approaches for adults and children with misophonia. J Affect Disord. 2022 11 01; 316:76-82.
    View in: PubMed
    Score: 0.014
  54. Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome. Int J Neuropsychopharmacol. 2002 Jun; 5(2):141-5.
    View in: PubMed
    Score: 0.014
  55. Provider perceptions of telehealth and in-person exposure and response prevention for obsessive-compulsive disorder. Psychiatry Res. 2022 07; 313:114610.
    View in: PubMed
    Score: 0.014
  56. Brief, parent-led, transdiagnostic cognitive-behavioral teletherapy for youth with emotional problems related to the COVID-19 pandemic. J Affect Disord. 2022 Mar 15; 301:130-137.
    View in: PubMed
    Score: 0.014
  57. Anxiety in Angelman Syndrome. Am J Intellect Dev Disabil. 2022 01 01; 127(1):1-10.
    View in: PubMed
    Score: 0.014
  58. Genetics of childhood disorders: XXXIV. Autoimmune disorders, part 7: D8/17 reactivity as an immunological marker of susceptibility to neuropsychiatric disorders. J Am Acad Child Adolesc Psychiatry. 2002 Jan; 41(1):98-100.
    View in: PubMed
    Score: 0.014
  59. Cost-effectiveness analysis of deep transcranial magnetic stimulation relative to evidence-based strategies for treatment-refractory obsessive-compulsive disorder. J Psychiatr Res. 2022 02; 146:50-54.
    View in: PubMed
    Score: 0.014
  60. Progress toward analysis of D8/17 binding to B cells in children with obsessive compulsive disorder and/or chronic tic disorder. J Neuroimmunol. 2001 Nov 01; 120(1-2):146-51.
    View in: PubMed
    Score: 0.014
  61. Perceptions of Deep Brain Stimulation for Adolescents with Obsessive-Compulsive Disorder. J Child Adolesc Psychopharmacol. 2021 03; 31(2):109-117.
    View in: PubMed
    Score: 0.013
  62. The Relationship of Family Accommodation with Pediatric Anxiety Severity: Meta-analytic Findings and Child, Family and Methodological Moderators. Child Psychiatry Hum Dev. 2021 02; 52(1):1-14.
    View in: PubMed
    Score: 0.013
  63. Age moderated-anxiety mediation for multimodal treatment outcome among children with obsessive-compulsive disorder: An evaluation with correspondence analysis. J Affect Disord. 2021 03 01; 282:766-775.
    View in: PubMed
    Score: 0.013
  64. Neural correlates of cognitive behavioral therapy response in youth with negative valence disorders: A systematic review of the literature. J Affect Disord. 2021 03 01; 282:1288-1307.
    View in: PubMed
    Score: 0.013
  65. The Impact of Comorbidity on Cognitive-Behavioral Therapy Response in Youth with Anxiety and Autism Spectrum Disorder. Child Psychiatry Hum Dev. 2020 08; 51(4):625-635.
    View in: PubMed
    Score: 0.013
  66. Serious negative consequences associated with exposure and response prevention for obsessive-compulsive disorder: A survey of therapist attitudes and experiences. Depress Anxiety. 2020 05; 37(5):418-428.
    View in: PubMed
    Score: 0.012
  67. Development and psychometric evaluation of the Mandarin Chinese version of the Yale-Brown Obsessive-Compulsive Scale - Second Edition. Braz J Psychiatry. 2019 Nov-Dec; 41(6):494-498.
    View in: PubMed
    Score: 0.012
  68. Cost-Effectiveness of Treatment Alternatives for Treatment-Refractory Pediatric Obsessive-Compulsive Disorder. J Anxiety Disord. 2020 01; 69:102151.
    View in: PubMed
    Score: 0.012
  69. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. J Anxiety Disord. 2019 12; 68:102149.
    View in: PubMed
    Score: 0.012
  70. The Centrality of Doubting and Checking in the Network Structure of Obsessive-Compulsive Symptom Dimensions in Youth. J Am Acad Child Adolesc Psychiatry. 2020 07; 59(7):880-889.
    View in: PubMed
    Score: 0.012
  71. Parents' Perceptions of Internalizing and Externalizing Features in Childhood OCD. Child Psychiatry Hum Dev. 2019 08; 50(4):692-701.
    View in: PubMed
    Score: 0.012
  72. Predictors of treatment outcome for youth receiving intensive residential treatment for obsessive-compulsive disorder (OCD). Cogn Behav Ther. 2020 07; 49(4):294-306.
    View in: PubMed
    Score: 0.012
  73. Incidence and clinical correlates of anger attacks in Chinese patients with obsessive-compulsive disorder. J Zhejiang Univ Sci B. 2019 Apr.; 20(4):363-370.
    View in: PubMed
    Score: 0.011
  74. Clinicians' perspectives of interfering behaviors in the treatment of anxiety and obsessive-compulsive disorders in adults and children. Cogn Behav Ther. 2020 01; 49(1):81-96.
    View in: PubMed
    Score: 0.011
  75. Evidence of prefrontal hyperactivation to food-cue reversal learning in adolescents with anorexia nervosa. Behav Res Ther. 2018 12; 111:36-43.
    View in: PubMed
    Score: 0.011
  76. Cognitive Behavioral Therapy for Childhood Anxiety Disorders: a Review of Recent Advances. Curr Psychiatry Rep. 2018 07 28; 20(8):65.
    View in: PubMed
    Score: 0.011
  77. Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions. J Clin Psychiatry. 1997; 58 Suppl 5:32-49.
    View in: PubMed
    Score: 0.010
  78. Subclinical obsessive-compulsive disorder in college students. Depress Anxiety. 1996-1997; 4(5):233-6.
    View in: PubMed
    Score: 0.009
  79. Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial. J Psychiatr Res. 2015 Dec; 71:140-7.
    View in: PubMed
    Score: 0.009
  80. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation. Biol Psychiatry. 1995 Aug 01; 38(3):138-49.
    View in: PubMed
    Score: 0.009
  81. Testing the disgust conditioning theory of food-avoidance in adolescents with recent onset anorexia nervosa. Behav Res Ther. 2015 Aug; 71:131-8.
    View in: PubMed
    Score: 0.009
  82. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder. Behav Res Ther. 2013 Dec; 51(12):823-9.
    View in: PubMed
    Score: 0.008
  83. Cerebral laterality, perception of emotion, and treatment response in obsessive-compulsive disorder. Biol Psychiatry. 1991 May 01; 29(9):900-8.
    View in: PubMed
    Score: 0.007
  84. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2010 Dec 01; 68(11):1073-6.
    View in: PubMed
    Score: 0.006
  85. Refining clinical judgment of treatment outcome in obsessive-compulsive disorder. Psychiatry Res. 2011 Feb 28; 185(3):394-401.
    View in: PubMed
    Score: 0.006
  86. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry. 2010 Aug; 71(8):e1-e21.
    View in: PubMed
    Score: 0.006
  87. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report. J Clin Psychiatry. 2010 Aug; 71(8):1040-6.
    View in: PubMed
    Score: 0.006
  88. Right and left dorsolateral pre-frontal rTMS treatment of refractory depression: a randomized, sham-controlled trial. Psychiatry Res. 2010 Aug 15; 178(3):467-74.
    View in: PubMed
    Score: 0.006
  89. Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study. Cogn Behav Ther. 2010; 39(1):24-7.
    View in: PubMed
    Score: 0.006
  90. Children's Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth. Child Psychiatry Hum Dev. 2009 Sep; 40(3):467-83.
    View in: PubMed
    Score: 0.006
  91. Four-factor structure of obsessive-compulsive disorder symptoms in children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2008 Jul; 47(7):763-772.
    View in: PubMed
    Score: 0.005
  92. Associations between miscellaneous symptoms and symptom dimensions in adults with obsessive-compulsive disorder. Anxiety Stress Coping. 2008 Apr; 21(2):199-212.
    View in: PubMed
    Score: 0.005
  93. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist. J Anxiety Disord. 2008 Dec; 22(8):1369-76.
    View in: PubMed
    Score: 0.005
  94. Obsessive-compulsive disorder in youth with and without a chronic tic disorder. Depress Anxiety. 2008; 25(9):761-7.
    View in: PubMed
    Score: 0.005
  95. Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder. Compr Psychiatry. 2008 Jan-Feb; 49(1):35-42.
    View in: PubMed
    Score: 0.005
  96. Family accommodation in pediatric obsessive-compulsive disorder. J Clin Child Adolesc Psychol. 2007 Apr-Jun; 36(2):207-16.
    View in: PubMed
    Score: 0.005
  97. Quality of life in youth with Tourette's syndrome and chronic tic disorder. J Clin Child Adolesc Psychol. 2007 Apr-Jun; 36(2):217-27.
    View in: PubMed
    Score: 0.005
  98. Further psychometric examination of the Tourette's Disorder Scales. Child Psychiatry Hum Dev. 2007 Aug; 38(2):89-98.
    View in: PubMed
    Score: 0.005
  99. Relationship of movements and behaviors to Group A Streptococcus infections in elementary school children. Biol Psychiatry. 2007 Feb 01; 61(3):279-84.
    View in: PubMed
    Score: 0.005
  100. Peer victimization in children with obsessive-compulsive disorder: relations with symptoms of psychopathology. J Clin Child Adolesc Psychol. 2006 Sep; 35(3):446-55.
    View in: PubMed
    Score: 0.005
  101. Reliability and validity of the Child Behavior Checklist Obsessive-Compulsive Scale. J Anxiety Disord. 2006; 20(4):473-85.
    View in: PubMed
    Score: 0.004
  102. Suicidality as a possible side effect of antidepressant treatment. J Clin Psychiatry. 2004 Jun; 65(6):742-9.
    View in: PubMed
    Score: 0.004
  103. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder. J Clin Psychiatry. 2003 Jun; 64(6):640-7.
    View in: PubMed
    Score: 0.004
  104. Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo. J Clin Psychopharmacol. 2001 Feb; 21(1):46-52.
    View in: PubMed
    Score: 0.003
  105. Possible role of neuropeptides in obsessive compulsive disorder. Psychoneuroendocrinology. 1999 Jan; 24(1):1-24.
    View in: PubMed
    Score: 0.003
  106. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997 Jun; 36(6):844-52.
    View in: PubMed
    Score: 0.003
  107. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Am J Psychiatry. 1997 Mar; 154(3):402-7.
    View in: PubMed
    Score: 0.002
  108. Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls. Biol Psychiatry. 1996 May 01; 39(9):776-83.
    View in: PubMed
    Score: 0.002
  109. A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. Am J Psychiatry. 1995 May; 152(5):772-7.
    View in: PubMed
    Score: 0.002
  110. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology. 1995 Feb; 12(1):73-86.
    View in: PubMed
    Score: 0.002
  111. A family study of obsessive-compulsive disorder. Am J Psychiatry. 1995 Jan; 152(1):76-84.
    View in: PubMed
    Score: 0.002
  112. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry. 1994 Oct; 51(10):782-92.
    View in: PubMed
    Score: 0.002
  113. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1994 Jul; 51(7):559-67.
    View in: PubMed
    Score: 0.002
  114. "Just right" perceptions associated with compulsive behavior in Tourette's syndrome. Am J Psychiatry. 1994 May; 151(5):675-80.
    View in: PubMed
    Score: 0.002
  115. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994 Apr; 51(4):302-8.
    View in: PubMed
    Score: 0.002
  116. Clomipramine in autism: preliminary evidence of efficacy. J Am Acad Child Adolesc Psychiatry. 1992 Jul; 31(4):746-50.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.